KMTS

Kestra Medical Technologies, Ltd. (KMTS)

Market Closed

12 Dec, 20:00

NASDAQ (NGS)

26. 22

+1.31

+5.26%

- Market Cap

- P/E Ratio

- Div Yield

367,124 Volume

- Eps

$ 24.91

Previous Close

Day Range

24.32 27.18

Year Range

13.25 30

Want to track KMTS and more in your Portfolio? 🎯

Get Started For Free

Earnings results expected in 2 days

Summary

KMTS closed today higher at $26.22, an increase of 5.26% from yesterday's close, completing a monthly increase of 7.28% or $1.78. Over the past 12 months, KMTS stock gained 14.25%.

KMTS is not paying dividends to its shareholders.

The last earnings report, released on Dec 11, 2025, exceeded the consensus estimates by 0.56%. On average, the company has surpassed earnings expectations by 0.45%, based on the last three reports. The next scheduled earnings report is due on Dec 15, 2025.

The stock of the company had never split.

The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

Overview
Earnings
News

KMTS Chart

Kestra Medical Technologies, Ltd. (KMTS) Q2 2026 Earnings Call Transcript

Seekingalpha | 1 day ago

Kestra Medical Technologies, Ltd. (KMTS) Q1 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS ) Q1 2026 Earnings Call September 11, 2025 4:30 PM EDT Company Participants Neil Bhalodkar - Vice President of Investor Relations Brian Webster - Founder, President, CEO & Director Vaseem Mahboob - Chief Financial Officer Conference Call Participants Travis Steed - BofA Securities, Research Division Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Michael Polark - Wolfe Research, LLC Presentation Operator Good afternoon, and welcome to the Kestra Medical Technologies Earnings Conference Call.

Seekingalpha | 3 months ago

Kestra Medical: Skipping A Heartbeat

Kestra Medical Technologies, Ltd. shows strong sales growth but faces significant operating losses and a concerning slowdown in sequential revenue growth. Despite a large addressable market and innovative cardiac device, the company's one-product focus and high valuation amplify risks. Recent quarters reveal only modest revenue increases, casting doubt on the sustainability of Kestra's growth trajectory post-IPO.

Seekingalpha | 6 months ago

Kestra Medical Technologies, Ltd. (KMTS) FAQ

What is the stock price today?

The current price is $26.22.

On which exchange is it traded?

Kestra Medical Technologies, Ltd. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is KMTS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Dec 15, 2025.

Has Kestra Medical Technologies, Ltd. ever had a stock split?

No, there has never been a stock split.

Affiliate Program About Terms Privacy Help Contact Us